Aastrom Biosciences (Aastrom) is a development stage regenerative medicine company, which is engaged in the development of autologous cell products for use in regenerative medicine. The company’s principal business is to develop Tissue Repair Cell (TRC) based products for use in multiple therapeutic areas including cardiac, vascular, bone and neural disorders. The company’s preclinical and clinical product development programs investigate the ability of patient-derived bone marrow stem and early progenitor cell populations to aid in regeneration of cardiac, vascular, bone and neural tissues. Aastrom is headquartered in Michigan, US
Aastrom Biosciences, Inc. – Pharmaceuticals & Healthcare – Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
To know more about this report kindly visit:
http://www.aarkstore.com/reports/Aastrom-Biosciences-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-21457.html
No comments:
Post a Comment